Related Experiment Video
Updated: Jan 13, 2026

Quantitative 3D In Silico Modeling q3DISM of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease
Published on: December 26, 2016
Shared Neuroinflammatory Mechanisms Across Dementia Types: An Integrative Review
Subramanian Thangaleela1, Asif Ali1, Yohanes Tandoro2
1Department of Nutrition, Chung Shan Medical University, 110, Sec. 1, Jianguo North Road, Taichung City 40201, Taiwan, China.
Neuroinflammation is central to dementia pathogenesis, impacting cognitive decline across various dementia types. Targeting shared inflammatory pathways offers promising therapeutic strategies for dementia treatment.
Area of Science:
- Neuroscience
- Immunology
- Pathology
Background:
- Dementia is a global neurodegenerative condition characterized by progressive cognitive decline.
- Distinct dementia types share common inflammatory pathways involving microglial and astrocyte activation.
- Neuroinflammation, driven by pro-inflammatory cytokines, contributes to synaptic dysfunction and neuronal degeneration.
Purpose of the Study:
- To explore the intricate mechanisms linking neuroinflammation to diverse dementia types.
- To identify shared and distinct neuroinflammatory pathways across different dementias.
- To unravel potential therapeutic strategies targeting neuroinflammation in dementia.
Main Methods:
- Review of current literature on dementia pathogenesis and neuroinflammation.
- Analysis of shared and distinct inflammatory mediators and cellular responses.
- Examination of advancements in neuroimaging and biomarker discovery for therapeutic targets.
Main Results:
- Neuroinflammation is a critical factor in the pathogenesis of all dementia forms.
- Activated microglial cells and astrocytes release pro-inflammatory cytokines, exacerbating neuronal damage.
- Despite varied pathologies, common inflammatory processes contribute to cognitive decline.
Conclusions:
- Shared neuroinflammatory mechanisms offer unified therapeutic targets for various dementias.
- Understanding distinct inflammatory pathways may lead to tailored dementia treatments.
- Targeting neuroinflammation holds significant potential for mitigating dementia progression.
More Related Videos
Related Concept Videos
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Dementia
The progression of dementia is generally gradual....
Alzheimer's Disease: Treatment
Neural Regulation
Role of Neurotransmitters in Memory
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...

